Ingersoll Rand Inc.

79.70+0.85 (+1.08%)

Oct 29, 4:00:02 PM EDT · NYSE · IR · USD

Upcoming Earnings

Report date

Oct 30, 2025 (today)

Key Stats

Market Cap

31.68B

P/E (TTM)

61.78

Basic EPS (TTM)

1.29

Dividend Yield

Recent Filings

10-Q

Q2 FY2025 results

7/31/25Jul 31, 2025

Ingersoll Rand posted Q2 revenues of $1,887.9 million, up 4.6% year-over-year from $1,805.3 million, driven by acquisitions adding $116.4 million while organic volumes dipped 5.2%; gross margin held steady at 43.7%. Operating income fell to $76.4 million from $271.8 million, hit by $229.7 million goodwill impairment and $36.1 million intangible impairment in Precision and Science Technologies, plus a $120.9 million equity investment loss, yielding a net loss of $115.3 million versus $185.0 million profit last year; diluted EPS swung to -$0.29 from $0.45, consistent with 400.5 million weighted shares. Acquisitions like SSI and Lead Fluid bolstered Industrial Technologies, contributing $26.2 million revenue post-close. Cash dipped to $1,310.6 million with $4,783.4 million debt, yet free cash flow reached $433.1 million YTD on $502.1 million operating cash; revolver offers $2,600 million availability. Acquisitions integrate smoothly, but competition in end-markets pressures margins.

8-K

Record Q2 orders, raised guidance

7/31/25Jul 31, 2025

Ingersoll Rand posted record Q2 2025 orders of $1,940 million, up 8%, and revenues of $1,888 million, up 5%, fueled by acquisitions and FX gains, yet organic growth dipped slightly amid volume pressures. Adjusted EBITDA climbed 3% to $509 million with a 27.0% margin, while non-cash impairments of $266 million hammered reported net loss to $115 million. Acquisitions bolstered the pipeline; the company raised full-year guidance for revenue 4-6%, Adjusted EBITDA $2.1-2.16 billion, and EPS $3.34-3.46. Impairments signal oil & gas and customer risks.

8-K

New board appointment announced

7/15/25Jul 15, 2025

Ingersoll Rand appointed Aurobind Satpathy, a senior McKinsey partner with nearly 30 years guiding multi-billion-dollar mergers and growth strategies, to its board effective July 15, 2025, expanding it to nine directors. He joins the Nominating and Corporate Governance and Sustainability Committees as an independent member. This bolsters strategic execution amid innovation push. Yet risks like integration challenges loom.

8-K

Leadership role expansion announced

6/17/25Jun 17, 2025

Ingersoll Rand expanded Michael Weatherred's role on June 12, 2025, to lead its Precision & Science Technologies segment while boosting his base salary to $600,000 and MIP target to 85%, effective June 16, with added equity grants valued at $300,000. Andrew Schiesl received supplemental equity awards totaling $450,000 to align with market norms. These moves aim to drive PST growth and margins. Yet risks could alter outcomes.

8-K

Annual meeting results

6/16/25Jun 16, 2025

Ingersoll Rand Inc. held its 2025 annual meeting on June 12, with 95% of shares participating. Stockholders elected eight directors, including Vicente Reynal and new board member Jennifer Hartsock, while ratifying Deloitte & Touche as auditors for fiscal 2025. An advisory vote also approved executive compensation. Strong support signals board stability amid industrial market pressures.

About

Ingersoll Rand Inc. provides various mission-critical air, fluid, energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services air and gas compression, vacuum, and blower products; fluid transfer equipment and loading systems; and power tools and lifting equipment, including associated aftermarket parts, consumables and services, air treatment equipment, controls, other accessories, and services under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, and other brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, automated liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for precision dosing, liquid and solid transfer, dispensing, gas compression and sampling, pressure management, flow control, powder handling, and other applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brands. This segment's products are used in medical, laboratory, life sciences, industrial manufacturing, water and wastewater, chemical processing, energy, food and beverage, agriculture, and other markets. It sells its products through an integrated network of direct sales representatives and independent distributors. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.

CEO

Mr. Vicente Reynal

IPO

5/12/2017

Website

https://www.irco.com

Employees

21,000

Sector

Industrials

Industry

Specialty Industrial Machinery